Internal Medicine, Hematology · Houston, TX
NPI
1588758510
Since 2006
Specialty
Internal Medicine, Hematology
Code 207RH0000X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
6550 Fannin St, Ste 1101
Houston, TX, 77030
Phone (713) 441-0006
Groups this clinician bills Medicare through
Medicare paid, 2024
$75K
886 services
Medicare patients, 2024
284
Average age 73
Drug cost, 2024
$1.7M
440 prescriptions
Company payments, 2025
$24K
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Lawrence Rice was code 99214 (office e&m - established), 259 times for 121 patients. In total Lawrence Rice billed 886 services in 18 codes, and Medicare paid $75K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-05-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 259 | 121 | $90.96 | $24K |
| 99232 Hospital E&M - Subsequent | Facility | 222 | 106 | $61.42 | $14K |
| 99215 Office E&M - Established | Office | 90 | 52 | $132.62 | $12K |
| 99222 Hospital E&M - Initial | Facility | 74 | 71 | $98.38 | $7,280 |
| 99233 Hospital E&M - Subsequent | Facility | 73 | 44 | $91.21 | $6,658 |
| 99231 Hospital E&M - Subsequent | Facility | 58 | 41 | $37.34 | $2,166 |
| 99223 Hospital E&M - Initial | Facility | 38 | 37 | $134.43 | $5,108 |
| 99213 Office E&M - Established | Office | 23 | 16 | $72.79 | $1,674 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 14 | 12 | $12.18 | $170 |
| 99221 Hospital E&M - Initial | Facility | 13 | 13 | $63.58 | $827 |
By year: 2022 $76K for 941 services; 2023 $72K for 847 services; 2024 $75K for 886 services.
Medicare prescription drug claims, 2024
In 2024, the drug Lawrence Rice prescribed most often to Medicare patients was Eliquis (Apixaban), with 77 prescriptions and refills. In total Lawrence Rice wrote 440 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 77 | 141 | 18 | $79K |
| Xarelto Rivaroxaban | 52 | 90 | Under 11 | $46K |
| Hydroxyurea Generic | 44 | 97 | 11 | $744 |
| Prednisone Generic | 20 | 40 | Under 11 | $138 |
| Pyrukynd Mitapivat Sulfate | 13 | 13 | Under 11 | $352K |
| Imbruvica Ibrutinib | 13 | 13 | Under 11 | $211K |
| Promacta Eltrombopag Olamine | 13 | 17 | Under 11 | $140K |
| Bosulif Bosutinib | 12 | 12 | Under 11 | $115K |
| Tasigna Nilotinib Hcl | 12 | 12 | Under 11 | $118K |
| Allopurinol Generic | 11 | 29 | Under 11 | $67 |
Brand drugs: 256 claims; generic drugs: 184 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Lawrence Rice $24K ($24K in general payments such as food, travel and fees) from 15 companies. The largest payer was Novartis Pharmaceuticals Corporation with $19K.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 16 | $19K |
| Genzyme Corporation SNY | 7 | $4,509 |
| Alexion Pharmaceuticals, Inc. AZN | 6 | $318 |
| Sobi, Inc SOBI.ST | 4 | $151 |
| Recordati_rare_diseases_inc. | 1 | $125 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $63.67 |
| Apellis Pharmaceuticals, Inc. APLS | 2 | $61.61 |
| Pfizer Inc. PFE | 2 | $51.92 |
| Pharmacosmos Therapeutics Inc. | 2 | $43.6 |
| Alnylam Pharmaceuticals Inc. ALNY | 1 | $36.31 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.